Gift Establishes Englander Institute
for Precision Medicine
JASON ANDRE W/GET TY IMAGES/ WCMC
Precision team: (From left) Physician-scientist Jonathan Zippin, MD-PhD; Chair of Dermatology Richard
Granstein, MD; Englander Institute Director Mark Rubin, MD; and physician-scientists Himisha Beltran, MD,
and Olivier Elemento, PhD. The Englander Institute’s expanded program will target additional areas of
oncology including melanoma, a rare but serious form of skin cancer.
Asignificant investment in Weill Cornell’s leading precision medicine program by Overseer Israel Englander and his wife, Caryl, will expand the scope of the institution’s approach to understanding and treating disease through therapies customized to patients’ unique genetic profiles.
The gift names the Caryl and Israel Englander Institute for Precision Medicine at Weill Cornell
“We are deeply grateful to the Englanders for their visionary gift, which will enable Weill Cornell to
transform the way we practice medicine,” said Dr. Laurie H. Glimcher, the Stephen and Suzanne Weiss
Dean of Weill Cornell Medical College. “Precision medicine offers great hope for understanding and
treating some of the most formidable diseases of our time, and the Englanders’ support will ensure that
we can continue our work to enhance the care we provide our patients, both now and into the future."
For more on the Englander Institute and precision medicine, see “A Precise Approach” on page 36.